Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mary M. Waybill"'
Publikováno v:
Human Immunology. 75:81
Aim The alloantibody response in solid organ transplantation is felt to be durable and long lasting. The durability of this response is appreciated in pretransplant patients where alloantibody can only be removed by plasmapheresis in combination with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::524b5923255cc09a751bb480b65d4b4a
https://doi.org/10.1016/j.humimm.2014.08.107
https://doi.org/10.1016/j.humimm.2014.08.107
Autor:
Harold C. Yang, Danielle Ladie, Seth C. Narins, Mary M. Waybill, Robert C. Scott, Kristina Krecko
Publikováno v:
Human Immunology. 73:105
Aim Antibody formation against human leukocyte antigens (HLA) is associated with graft dysfunction and loss in renal transplant recipients. We have previously shown that recipients with positive leukocyte antibody panel (LABB) tests demonstrate signi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c271cc9bece7ef387a284ae779b1bfc5
https://doi.org/10.1016/j.humimm.2012.07.210
https://doi.org/10.1016/j.humimm.2012.07.210
Publikováno v:
Journal of Cardiac Failure. 4:49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::936c333a448a9b4b811f2ee2d483daee
https://doi.org/10.1016/s1071-9164(98)90182-8
https://doi.org/10.1016/s1071-9164(98)90182-8
Autor:
Lionel Rostaing, Suphamai Bunnapradist, Josep M. Grinyó, Kazimierz Ciechanowski, Jason E. Denny, Helio Tedesco Silva, Klemens Budde, Sanjay Kulkarni, Donald Hricik, Barbara A. Bresnahan, Rafik A. El-Sabrout, Laurence K. Chan, Gaetano Ciancio, Mohamed A. El-Ghoroury, Michael J. Goldstein, Robert S. Gaston, Reginald Y. Gohh, Mary T. Killackey, Anne King, Richard J. Knight, Arputharaj H. Kore, Debra L. Sudan, Javier Chapochnick Friedmann, Shamkant P. Mulgaonkar, Charles Nolan, Oleh G. Pankewycz, John D. Pirsch, Heidi M. Schaefer, Steven M. Steinberg, Bruce E. Gelb, Karin A. True, Patricia M. West-Thielke, Mary M. Waybill, Joshua H. Wolf, Beverley L. Ketel, Robert C. Harland, Fuad S. Shihab, Elisabeth Cassuto, Yannick Le Meur, Christophe Mariat, Josep Maria Grinyó, Jose Puig, Daniel Seron, Giuseppe Tisone, Bartosz Foroncewicz, Zbigniew Wlodarczyk, Oliver Witzke, Guillermo A. Mondragon, Eduardo Mancilla Urrea, Josefina Alberu Gomez, Rafael Reyes Acevedo, Maria del Carmen Rial, Pablo A. Novoa, Helio T. Silva, Valter D. Garcia, Deise D. Carvalho, Luciana T. Santamaria Saber, Fabiana L. Contieri, Marcos G. Bastos, Roberto C. Manfro, John Kanellis, Josette Eris, Philip O’Connell, Peter Hughes, Graeme Russ, Grant B. Pidgeon, Ian D. Dittmer, Terence Kee, Anantharaman Vathsala, Radomir Naumovic, Igor Mitic, Randhawa Parmjeet
Publikováno v:
American Journal of Kidney Diseases. (4):648-659
Background1-year data from this trial showed the noninferiority of a novel once-daily extended-release tacrolimus (LCPT; Envarsus XR) to immediate-release tacrolimus (IR-Tac) twice daily after kidney transplantation.Study DesignFinal 24-month analysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52de67cbb5744401dbcd18959497af8e